Question 1

Am I eligible for this trial based on my current health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. clinical trial (NCT00474955). Contact the study team or your healthcare provider for specific answers.

Question 2

How does PEGASYS compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. clinical trial (NCT00474955). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of PEGASYS?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. clinical trial (NCT00474955). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my kidney function be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. clinical trial (NCT00474955). Contact the study team or your healthcare provider for specific answers.

Question 5

What will the treatment schedule look like for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. clinical trial (NCT00474955). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens after the 48 weeks of treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure. clinical trial (NCT00474955). Contact the study team or your healthcare provider for specific answers.

What this study is about